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Pharmaceuticals are the chemical substances containing one or sev-
eral pharmacologically active ingredients and excipients — substances
which are added to a prescription in order to confer a suitable consisten-
cy or form of the drug aswell as to affect the bioavailability of the active
ingredients (Jackson, Young, & Pant, 2000; Pifferi & Restani, 2003;
World Health Organization, 2007). The quality control of pharmaceuti-
cals is a key factor at all stages of their development and production. In
recent years, the international pharmacopoeia requirements and stan-
dards related to the quality control of pharmaceuticals become stricter
(Pimenta, Montenegro, Araujo, & Martınez Calatayud, 2006; World
Health Organization, 2007). This demands the modern pharmaceutical
analysis to develop rapid, reliable, selective and sensitive analytical
methods for the determination of active ingredients and excipients in
pharmaceuticals (David & Webb, 2003).
Nowadays, by the reason of the accelerated pace of life, hyponutrition,
people are exposed by a lacking of essential trace elements, amongwhich
themost common is iron deﬁciency. Iron is of vital importance in numer-
ous biological processes, primarily involved oxygen binding and trans-
port, muscle oxygen use and storage, gene regulation, cell growth and
differentiation, enzyme reactions, neurotransmitter synthesis, and pro-
tein synthesis (Beard, 2001; Crichton, Wilmet, Legssyer, & Ward, 2001;
Halliberg, 2001; Schumann, Ettle, Szegner, Elsenhans, & Sololmons,
2007). The lack of this element in the human body causes a widespread7 812 372 4421.disease — iron-deﬁciency anemia (IDA) (Clark, 2008). The treatment of
IDA is provided by the antianemic drugs which contain iron (II) com-
pounds and ascorbic acid as themostly used excipient, which improves
the gastrointestinal absorption of iron (Killip, Bennett, & Chambers,
2007). However, such pharmaceuticals often cause side effects: nausea,
anorexia, diarrhea and metal taste in the mouth (Beutler, Hoffbrand, &
Cook, 2003). Thus, it is important to carry out the quality control of
antianemic drugs and determine the concentrations of iron (II) and
ascorbic acid.
Traditionally, most methods of pharmaceutical analysis for separate
determination of iron (II) and ascorbic acid are focused on the spectro-
photometry (Davies & Masten, 1991; Guclu, Sozgen, Tutem, Ozyurek, &
Apak, 2005; Karpinska & Kulikowska, 2002; Zargba & Hopkata, 1996)
and electrochemistry (Mahmoud, 2001; Mary Nancy, Anithakumary, &
Kumara Swamy, 2014; Merli, Profumo, & Dossi, 2012; Thangamuthu,
Senthil Kumar, & Chandrasekara Pillai, 2007) (Table 1). These methods
are characterized by high selectivity, sensitivity, rapidity and the possi-
bility of automation. However, these techniques as well as atomic ab-
sorption and emission spectrometry (Zachariadis & Michos, 2007;
Zachariadis, Raidou, Themelis, & Stratis, 2002) are primarily focused
on the determination of iron. In turn, the chromatography (Gioia,
Andreatta, Boschetti, & Gatti, 2008; Khuhawar & Lanjwani, 1998;
Pengfei et al., 2012) and the capillary electrophoresis (Fotsing, Fillet,
Bechet, Hubert, & Crommen, 1997; Lin Ling, Baeyens, Van Acker, &
Dewaele, 1992) are focused on the determination of iron (II) or ascorbic
acid.
Inevitably, automation plays an important role in pharmaceutical
analysis, especially when a lot of samples have to be analyzed in the
Table 1
Reported methods for determination of iron (II) and ascorbic acid in pharmaceuticals.
Method of analysis Analyte Detection Matrix Linear range,
mg L−1
LOD,
mg L−1
Sample
frequency
(h−1)
R.S.D.,
%
Reference
Spectrophotometry Iron (II) With 4-(2-pyridylazo) resorcinol at λ= 537 nm,
pH = 9.1 (borate buffer)
Tablets 0.025–0.2 0.008 10 2.2 Karpinska &
Kulikowska
(2002)
With three azoderivatives of pyrocatechol at
λ= 490; 560; 600 nm, pH = 10.0;
Tablets 0.05–2.11
0.05–0.89
0.05–1.00
0.01
0.01
0.01
10 3.0
2.7
1.9
Zargba &
Hopkata (1996)
Ascorbic acid With neocuproine at λ= 450 nm, pH = 7.0 Tablets 1–15 0.3 10 2.0 Guclu et al.
(2005)
With sodium 2,6-dichlorophenolindophenol at
λ= 520 nm, pH = 4.2
Tablets 0.3–20 0.08 10 1.8 Davies &
Masten (1991)
Electrochemical
methods
Iron (II) Differential pulse voltammetry, pH = 7.0 Tablets 0.05–5 0.017 5–10 3.6 Merli et al.
(2012)
Potentiometric detection with ion-selective
electrode, pH = 7.0
Tablets 0.028–560 0.006 5–10 2.6 Mahmoud
(2001)
Ascorbic acid Amperometric detection using glassy carbon
electrode modiﬁed by K4Mo(CN)8, pH = 7.0
Tablets 2–100 0.5 5–10 3.5 Thangamuthu
et al. (2007)
Differential pulse voltammetry with glassy carbon
electrode modiﬁed by graphene, pH = 7.0
Tablets 8–80 0.7 5–10 3.0 Mary Nancy
et al. (2014)
AAS/AES Iron (II) AES with inductively coupled plasma Tablets 0.01–0.5 0.002 10 2.3 Zachariadis &
Michos (2007)
AAS with ﬂame atomization (air-acetylene ﬂame) Tablets 0.5–4 0.15 10–20 1.1 Zachariadis
et al. (2002)
Chromatography Iron (II) Preliminary derivatization HPLC complexing agent
(2-thiophene aldehyde-4-phenyl-3-tiosemicarbazone),
stationary phase — C-18; mobile phase — a mixture of
methanol, acetonitrile, water, sodium acetate and
ammonium tetra butylbromide (78:10:10:1:1)
Tablets 0.5–2.5 0.025 4 4.8 Khuhawar &
Lanjwani
(1998)
Ascorbic acid HPLC stationary phase — C-18; mobile phase — a
mixture of phosphate buffer and acetonitrile (95:5)
Tablets 0.4–1.2 0.13 10 2.0 Pengfei et al.
(2012)
Couple-ion reversed liquid chromatography;
stationary phase — C-18, mobile phase —
cetyltrimethylammonium bromide solution
Injection
solutions
14–45 2 10 1.8 Gioia et al.
(2008)
Capillary
Electrophoresis
Ascorbic acid Detection in the medium of a borate buffer solution
(pH = 8.5)
Tablets 0.2–1 0.02 6 4.3 Fotsing et al.
(1997)
Detection in the medium of a phosphate buffer
solution (pH = 5.0)
Tablets 10–1000 0.5 12 5.0 Lin Ling et al.
(1992)
Flow analysis Iron (II) FIA, reagent — salicylic acid, λ= 520 nm, pH = 4.0 Tablets 1–20 0.3 100 3.4 Udnana et al.
(2004)
SIA, reagent — 1,10-phenanthroline,λ= 510 nm,
pH = 5.5
SIA, reagent — 2,2-bipyridyl, λ= 523 nm, pH = 4.5
Tablets
Tablets
0.25–5
5.0–40
0.02
1.0
40
100
3.0
5.0
Tesfaldet et al.
(2004)
Oliveira &
Masini (2001)
Ascorbic acid FIA, reagent — ferrozine, λ= 562 nm, pH = 5.5 Tablets 0.1–20 0.005 90 1.9 (Molina-Diaz
et al., 1998)
FIA, reagent — tripiridilttriazin iron (III), λ= 593
nm, pH = 3.6
Tablets 0.015–2 0.005 180 0.8 Kukoc-Modun
et al. (2012)
SIA, reagent — KMnO4, λ= 525 nm Tablets 0.1–1000 0.03 60 2.0 Lenghor et al.
(2002)
Iron (II) and Ascorbic
acid simultaneously
Flow sandwich technique, reagent for Iron (II) —
1,10-phenanthroline, λ= 510 nm, pH= 5.5
reagent for Ascorbic acid — sodium
2,6-dichlorophenolindophenol, λ= 512 nm, pH= 4.5
Tablets 0.5–4
2–20
0.2
0.7
41 3.0
3.0
This
work
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the ﬂow injection (FIA) (Ruzicka & Hansen, 1975) and sequential injec-
tion (SIA) analysis (Ruzicka & Marshall, 1990). Coupling to FIA and SIA
manifolds selective detectors make the developed approaches simple
and easy implemented in pharmaceutical analysis (Horstkotte &
Cerdà, 2009; Mervartova, Polasek, & Martınez Calatayud, 2007). Thus,
ﬂow analysis with spectrophotometric detection offers practically
endless possibilities to the automation of pharmaceutical analysis
procedures. Moreover it also provides miniaturization of analysis
(Tzanavaras & Themelis, 2007).
For the determination of iron (II) and ascorbic acid in pharmaceuticals
the ﬂow injection (Alonso, Bartrolí, del Valle, & Barber, 1989; Alonso,
Bartroli, Delvalle, Escalada, & Barber, 1987; Alonso-Chamarro, Bartroli, &
Barber, 1992; Araujo, Lima, Alonso-Chamarro, Bartroli, & Poch, 1991;
Cerda & Cerda, 2009; Falkova, Pushina, Bulatov, Alekseeva, & Moskvin,
2014; Horstkotte & Cerdà, 2009; ISO 5725-1, 1994; IUPAC, 1997;Kukoc-Modun, Biocic, & Radic, 2012; Lenghor et al., 2002; Mervartova
et al., 2007; Molina-Diaz, Ortega-Carmona, & Pascual-Reguera, 1998;
Mortatti, Krug, Pessenda, & Zagatto, 1982; Ruzicka & Hansen, 1975;
Ruzicka & Marshall, 1990; Tzanavaras & Themelis, 2007; Udnana et al.,
2004) and sequential injection (Lenghor et al., 2002; Oliveira & Masini,
2001; Tesfaldet, van Staden, & Stefan, 2004) techniques were developed,
which provide high sensitivity (Table 1) in combination with high sam-
pling frequency (up to 180 h−1). However, they are focused only on the
determination of iron (II) or ascorbic acid. To the best of our knowledge,
simultaneous separate determination of iron (II) and ascorbic acid
based on ﬂowmethods has not been reported.
This present work describes a new automated procedure for simul-
taneous separate determination of iron (II) and ascorbic acid in pharma-
ceuticals. For this purpose the ﬂow system based on sandwich
technique is implemented. At ﬁrst the application of this technique in
ﬂow analysis was presented by Alonso and co-authors and was applied
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ples (Alonso et al., 1989). The sandwich technique provides the strict
order of reagents and sample injection into the ﬂow system and
means the sample “sandwiching” between two selective reagents
(Alonso et al., 1987; Alonso-Chamarro et al., 1992; Araujo et al., 1991).
During the moving thought the reaction coil two analytical products
are formed. Despite the necessity to use the relatively large sample vol-
ume for preventing the overlapping of the colored zones, the sandwich
technique is characterized by satisfactory sampling frequency because
of the highﬂow rate using.Moreover, because of the optimizing of phys-
ical parameters of the ﬂow systems it become possible to achieve the
excellent repeatability of analysis and considerable reagent saving
(Cerda & Cerda, 2009).
2. Materials and methods
2.1. Reagents and solutions
All chemicals were of analytical reagent grade. Ultra pure water
from Millipore Milli-Q RG (Millipore, USA) was used throughout the
experiment. The stock solution of 0.045 M of iron (II) was prepared by
dissolving of the corresponding weight of FeSO₄ · (NH₄)2SO₄ · 6H2O
in 0.1MH2SO4. The stock solution of 0.1Mof ascorbic acidwasprepared
by dissolving of the correspondingweight in thewater. Theworking so-
lutions of analytes were prepared by appropriate dilution of the stock
solutions with the water. The solution of 1 μМ 1,10-phenanthroline
and sodium 2,6-dichlorophenolindophenol were prepared by dissolv-
ing of the corresponding weights of reagents in the acetate buffer solu-
tion (рН= 4.5) and the water, respectively. The 1,10-phenanthroline
solution was colorless, stable within a week when stored in the dark
place. The solution of sodium 2,6-dichlorophenolindophenol was
brightly colored, stable within a week when stored at temperature
from 2 to 5 °С. The working solutions of reagents were prepared by ap-
propriate dilution of the stock solutions with acetate buffer solution.
2.2. Manifold and apparatus
The ﬂow system based on sandwich technique includes (Fig. 1): an
eight-port valve (Cole-Parmer, USA), a peristaltic pump MasterFlex L/S
(Cole-Parmer, USA) (ﬂow rate 3.0 mL min−1), a reaction coil (80 cm
length and 1 mm in i.d.), home-made PTFE ﬁlter prepared according
to Falkova et al. (2014) for ﬁltering a sample solution and communica-
tion tubes (PTFE1mmin i.d.). It is equippedwith a source of visible lightFig. 1. The manifold of the ﬂow systeLS-1 and a USB 4000 spectrometer (Ocean Optics, USA) with a 50 mm
path length ﬂow cell FIA-Z-SMA-50-TEF (Fialab, USA). The analyzer
was operated automatically by means a computer.
To carry out the reference analyses of pharmaceuticals a capillary
electrophoresis system Capel-105М (Lumex, Russia) and an atomic ab-
sorption spectrometer АА-7000 (Shimadzu, Japan) were used. To carry
out the sampling preparation of pharmaceuticals an ultrasonic bath
Sapphire (Sapphire, Russia) was used.
2.3. Samples
Three different samples of antianemic drugs at solid dosage form
“Sorbifer Durules”, “Fenules” and “Tardyferon” were analyzed. All
these antianemic drugs contain ferrous sulfate as active ingredient and
ascorbic acid as excipient, with dosage form 500 mg.
2.4. Sample preparation
The sample preparation was performed by ultrasound-assisted dis-
solution of solid dosage form of antianemic drugs in the medium of
0.1MHCl. Three tablets of antianemic drugs were grounded to a homo-
geneous powder in a ceramic mortar. Then, 0.01 g of the powder was
mixed with 1 g of potassium chloride. This step is carrying out because
of the high content of iron (II) and ascorbic acid in antianemic drugs.
Further, 0.01 g of the obtained mixture was placed in a glass vessel
and the 5 mL of 0.1 M HCl was added. Afterwards the dissolution of
antianemic drugs took place under ultrasonication (325 W, 35 kHz) at
20 °C for 10 min. The prepared solution was then analyzed by ﬂow sys-
tem based on sandwich technique. While the calculation of the content
of the iron (II) and ascorbic acid in the tablet, the mass of the tablet
and the analyte content using the calibration curve were taken into
consideration.
2.5. The procedure of ﬂow determination of iron (II) and ascorbic acid
To implement the ﬂow system based on sandwich technique (Fig. 1)
the portions of sample and reagent solutions were sequentially deliv-
ered into the reaction coil bymovement of the peristaltic pump through
a eight-port valve in strict order: 75 μL of acetate buffer solution as the
carrier solution (g), 150 μL of 1,10-phenanthroline solution (b), 1 mL
of sample solution (a), 150 μL of sodium 2,6-dichlorophenolindophenol
solution (d) and again 500 μL of carrier solution (g). The high ﬂow rate
(3.0mLmin−1) and a large volume of the sample eliminate overlappingm based on sandwich technique.
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were measured in the ﬂow-stop condition for 3 s by means of the spec-
trophotometer at the wavelength 510 nm for iron (II) and 512 nm for
ascorbic acid. The ﬁrst analytical signal corresponds the complex of
iron (II) with 1,10-phenanthroline, the second one — the product of
ascorbic acid with sodium 2,6-dichlorophenolindophenol. To avoid the
memory effect the manifold was washed out with carrier solution. To
ensure the strict order of zones formation, sequence and time of
performing of all analysis steps the special program was set up.
2.6. Procedure for the determination of iron (II) and ascorbic acid by
reference methods
For the AAS determination of iron (II) in antianemic drugs the pre-
treatment stage was performed by ultrasound-assisted dissolution of
powdered tablets in 50 mL of 1 M HNO3 for 10 min. Then, the mixture
was ﬁltered through the paper ﬁlter and farther analyzed by AAS with
atomization in a continuous ﬂame.
For the CE determination of ascorbic acid in antianemic drugs the
pre-treatment stage was performed by ultrasound-assisted dissolution
of powdered tablets in 5mLof 0.1MHCl for 10min. For the stabilization
of ascorbic acid in the prepared solution 10 mL of 0.05 M EDTA was
added. Then, the mixture was ﬁltered through the paper ﬁlter and far-
ther analyzed by capillary electrophoresis. The length of used quartz
capillary was 50 cm with 75 μm in i.d. The measurements were per-
formed at 254 nm using Na2B4O7 — sodium dodecyl sulfate solution as
a supporting electrolyte.
3. Results and discussion
3.1. Theoretical aspects
For the spectrophotometric determination of iron (II) a well-known
color-forming reagent 1,10-phenanthrolinewas used. This reaction pro-
ceeds in wide range of pH from 2.0 to 9.0 in a molar ratio 3:1 (R:Fe2+)
(Mortatti et al., 1982). The complex absorbance maxima is observed at
the 510 nm (ε510 = 1.1 × 104 L mol−1 cm−1).
For the spectrophotometric determination of ascorbic acid the re-
agent sodium 2,6-dichlorophenolindophenol was chosen, because of
the reducing properties of the analyte. This reaction proceeds in a
molar ratio 1:1 according to the following schematic representation:
In the acidic medium the reagent solution has a purple color, which
is discoloring during the interaction with ascorbic acid. Absorbance
maximum of sodium 2,6-dichlorophenolindophenol is observed at the
512 nm (ε512 = 3.2 × 104 L mol−1 cm−1).Fig. 2. Absorbance spectra of complex of Fe (II) with 1,10-phenanthroline (СR = 10−4М,
CFe2+ = 10−4М, рН= 4.5) and sodium 2,6-dichlorophenolindophenol (СR = 10−4М,
ascorbic acid = 10−4М, рН= 4.5).The absorbance spectra of complex of Fe (II) with 1,10-
phenanthroline and sodium 2,6-dichlorophenolindophenol are pre-
sented in the Fig. 2.
The reaction between ascorbic acid and sodium 2,6-
dichlorophenolindophenol is strongly dependent on the acidity of
the medium. However, solving the problem of choosing the optimal
pH of the reaction, it was necessary to take into account the presence
of iron (II) in the antianemic drugs and its possible inﬂuence on the re-
action. According to Davies &Masten (1991), itwas decided to carry out
the reaction in the presence of acetate buffer solution. In the pH range
from 4.0 to 4.5 the interference effect of Fe2+ ions is not found. Thus,
the acetate buffer solution (pH = 4.5) was used as an appropriate
carrier-solution.
3.2. Optimization of parameters
The conditions for the determination of iron (II) and ascorbic acid
were optimized by studying the inﬂuence of the various parameters
such as ﬂow rate, sample and reagent volumes, reaction coil length
and reagent concentration. 4 × 10−5 M of iron (II) and ascorbic acid,
5 × 10−3 M of 1,10-phenanthroline and 5 × 10−4 M of sodium 2,6-
dichlorophenolindophenol were used to optimize these parameters. In
all cases both the relative peak height and percentage of RSD were
used as criteria for establishing the most appropriate parameters.
The ﬂow rate is a very important parameter to be optimized because
it inﬂuences to the products formation. The reactions between iron (II)
and 1,10-phenanthroline as well as ascorbic acid and sodium 2,6-
dichlorophenolindophenol are rapid, resulting in an almost instant
products formation. The ﬂow rate was varied between 0.5 and
3.5mLmin−1 by changing the speed of the pump. The better repeatabil-
ity and lower consumption of carrier-solution was achieved at
3.0 mL min−1 and this ﬂow rate was chosen as optimumworking con-
dition (Fig. 3A).
The aim of optimization of sample and reagent volumes is to mini-
mize the consumption of sample and reagents, maintaining the best
sensitivity and repeatability and to prevent the mixing of products
while moving them in the reaction coil into the detector. The injected
sample volume was varied from 0.5 to 1.5 mL and the volumes of
1,10-phenanthroline and sodium 2,6-dichlorophenolindophenol
were varied from 50 to 250 μL. The results presented in the Fig. 3B
shown that the injected sample volume less than 1mL leads to decreas-
ing of repeatability because product zonemixing is observed. Itwas also
found that optimal reagent volumes are 150 μL for both reagents
(Fig. 3C).
The reaction coil is usually kept as short as possible to avoid the
product dispersion but sufﬁcient to provide the product formation.
The length of this coil was varied from 50 to 100 cm. The optimum
length of the reaction coil was 80 cm, which ensures the effective over-
lapping zones of reagents with the sample and prevent the mixing of
products zones (Fig. 3D).
The concentrations of the reagents were varied from 1 × 10−3 to
1 × 10−2 M of 1,10-phenanthroline and from 1 × 10−4 to 1 × 10−3М
of sodium 2,6-dichlorophenolindophenol. It was found that the
optimal concentrations of 1,10-phenanthroline and sodium 2,6-
dichlorophenolindophenol are 5 × 10−3 and 5 × 10−4М, respectively.
3.3. Optimization of dissolution
Most of antianemic drugs are in a solid dosage formwith a relatively
high content of iron (II) and ascorbic acid (13–20%). Therefore, it is im-
portant to provide the effective dissolution as well as dilution of the
sample. It is known that H2SO4 and HNO3 have strong oxidizing proper-
ties, which contribute to the destruction of ascorbic acid and oxidation
of Fe2+ to Fe3+. Thus for investigating of the sample dissolution the
deionized water and HCl were used. The effects of temperature,
thermostating and ultrasonication time were investigated to increase
Fig. 3. Investigation of ﬂow system based on sandwich technique experimental conditions: (A) effect of ﬂow rate, (B) effect of sample volume, (C) effect of reagents volumes, (D) effect of
reaction coli length.
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to 50 °C and the thermostating and ultrasonication time — from 2 to
20 min. Two parallel experiments were performed —with and without
ultrasound assistants. The results showed that effective dissolution of
antianemic drugs is observed in the media of 0.1 M HCl at 50 °С
for 10 min without ultrasonication and at 20 °C for 10 min with
ultrasonication.
3.4. Interference effect
The effect of potentially interfering components presented in
antianemic drugs (Mg2+, Co2+, Cu2+, SO42− ions and riboﬂavin,
pyridoxine, thiamine and pantothenic acid) on the determination of
analytes was investigated. It was performed by addition of known con-
centration of each component into amodel solution, containing iron (II)
ions and ascorbic acid at concentration of 4 × 10−5М in 0.1 M hydro-
chloric acid. The tolerable excess of each taken foreign species is consid-
ered to be less than 5% of relative error in the signal. The greatest
inﬂuence (less than 10-fold excess) on the product formation has ribo-
ﬂavin, thiamine, pyridoxine and pantothenic acid, but in the antianemic
drugs a content of these components is much lower than the content of
iron (II) and ascorbic acid. Thus it should be concludedwith the absence
of interference effect.
3.5. Validation
For validation, the following parameterswere evaluated for linearity
and sensitivity, precision, recoveries and accuracy.
3.5.1. Linearity and sensitivity
Under the optimized reaction condition according to the previously
described procedure, the calibration curves for iron (II) and ascorbic
acid determination were constructed from ten data points using the
standard solution of analytes (Fig. 4). The relationship obtainedbetween the relative peak height and concentrations of iron (II) as
well as ascorbic acid were given by the follow equations:
Relative peak height ¼ 0:231 Concentration of Fe IIð Þ; mg L−1
h i
þ 0:062; r2 ¼ 0:996;
Relative peak height ¼−0:046 Concentration of ascorbic acid IIð Þ; mg L−1
h i
þ 0:0968; r2 ¼ 0:995:
The absorbance of colored products at the wavelength 510 nm and
512 nm for iron (II) and ascorbic acid, respectively, obey the Beer's
law in the range of 0.5–4.0 mg L−1 for iron (II) and of 2.0–20 mg L−1
for ascorbic acid.
The sensitivity was characterized by the limit of detection (LOD). It
was measured by standard IUPAC method as 3 standard deviation of
the blank (3 s) (IUPAC, 1997). The LODs calculated from the calibration
plots based on 3 swere 0.2mg L−1 for iron (II) and 0.7mg L−1 for ascor-
bic acid. The results indicated that the LODs both for iron (II) and ascor-
bic acid are satisﬁed for their determination in antianemic drugs.
3.5.2. Precision
The precision of themethodwas evaluatedwith regard to its repeat-
ability and reproducibility (ISO 5725-1, 1994).
The repeatability of the developed approach was determined by an-
alyzing 10 replicates of model solutions which contain iron (II) and
ascorbic acid in the range from 0.5 mg L−1 to 4.0 mg L−1 and from
2 mg L−1 to 20 mg L−1, respectively. It was studied that the developed
ﬂow sandwich-type approach provides satisfactory results. The RSD
values were b3.0%. This level of precision of the proposed ﬂow
sandwich-type approachwas adequate for quality-control of antianemic
drugs.
The reproducibility of the proposedmethodswas assessed by apply-
ing thedevelopedﬂow sandwich-type approachwith theuse of 2 differ-
ent instruments in 2 different laboratories at 2 different times. Results
Fig. 4. Calibration curves and depiction of absorbance peaks obtained by suggested ﬂow system based on sandwich technique.
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were found to be reproducible because the RSD values under conditions
were 5.0%.
3.5.3. Recovery
Recovery values were determined for each analyte at 2mg and 5mg
concentrations in dosage form of antianemic drugs. The investigation
was performed for 3 replicate of three samples (“Sorbifer Durules”,
“Fenules”, “Tardyferon”). The standard additions of analytes were
placed into the samples of antianemic drugs before dissolving. It is
shown in Table 2 that recovery values for both analytes are between
98 and 102%.
3.5.4. Accuracy
The available solid dosage formof antianemic drugswas analyzed by
proposed approach and by reference methods: AAS for iron determina-
tion and CE for ascorbic acid determination. It should be pointed out
that in the presence of ascorbic acid iron exists in the form of Fe (II).
The accuracy of the approach was evaluated by the comparison of the
results receiving by both approaches. The obtained results represent
no signiﬁcant differences in iron (II) and ascorbic acid concentrations
obtained by suggested and reference methods (Table 2). Student's
t-test of statistical hypotheses about the equality of the means wasTable 2
The results of the iron (II) and ascorbic acid determination in antianemic pharmaceuticals (F-c
Drug Labeled value,
mg/tablets
Added
amount,
mg/tablets
The developed
method,
mg/tablets
ААS, mg/tablets F-value
Fe (II) AA Iron (II)
Sorbifer Durules 100 60 0 95 ± 5 96 ± 8 2.5
2 96 ± 5 97 ± 7 1.1
5 101 ± 5 100 ± 8 2.3
Fenules 55 50 0 58 ± 3 60 ± 5 4.3
2 61 ± 4 62 ± 6 2.7
5 64 ± 5 65 ± 6 1.3
Tardyferon 80 – 0 69 ± 4 70 ± 5 1.9
2 72 ± 4 71 ± 4 0.7
5 74 ± 5 75 ± 6 1.6used to test the equality of themeans of the experimental data obtained
by developed method and by the reference method. Hypothesis about
the equality of the means of the experimental data obtained by the de-
velopedmethod and by the referencemethodwas taken as the null hy-
pothesis (H0). Hypothesis about the difference ofmentionedmeanswas
taken as an alternative hypothesis (H1). The signiﬁcance was taken
equal to the 0.05 level. Based on the obtained results, the observed
differences were not contrary to the hypothesis H0 and the obtained
discrepancies with the 0.05 signiﬁcance level could be considered
insigniﬁcant.
4. Conclusion
In comparison with the previously reported ﬂow approaches
(Kukoc-Modun et al., 2012; Lenghor et al., 2002; Molina-Diaz et al.,
1998; Oliveira & Masini, 2001; Tesfaldet et al., 2004; Udnana et al.,
2004) the ﬂow systembased on sandwich technique has been proposed
for the simultaneous separate determination of iron (II) and ascorbic
acid in antianemic pharmaceuticals for the ﬁrst time. Taking into ac-
count high content of analytes (13–20%) in the pharmaceuticals the
LOD values of the developed approach are quite satisfactory. The sample
frequency of the developed approach is comparablewith the previously
reported ﬂow approaches, because during the one ﬂow cycle it isritical = 19.0, t-critical = 4.3, P = 0.95, n = 3).
t-value Recovery,
%
The developed
method,
mg/tablets
CE, mg/tablets F-value t-value Recovery,
%
Ascorbic acid
0.5 – 58 ± 4 57 ± 2 7.0 1.1 –
0.3 99 61 ± 5 60 ± 6 1.6 0.7 101
0.5 101 63 ± 5 62 ± 5 1.7 0.5 101
1.8 – 66 ± 5 67 ± 3 5.2 0.5 –
0.6 98 69 ± 4 70 ± 4 1.0 0.8 99
0.8 99 72 ± 5 73 ± 4 4.0 0.8 99
0.7 – 86 ± 4 87 ± 3 1.8 0.3 –
0.5 101 88 ± 4 90 ± 5 1.3 1.3 102
0.4 99 91 ± 4 93 ± 5 1.7 1.1 98
62 C. Vakh et al. / Journal of Pharmacological and Toxicological Methods 73 (2015) 56–62possible to analyzed two analytes. The proposed procedure is of great
value in quality-control analysis of the developed pharmaceuticals,
because it improves automation, miniaturization, simplicity, sensitivity,
ﬂexibility and low cost.
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